Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: The influence of very-low-calorie diet

Molecular and Cellular Endocrinology

Volumn 361, Issue 1-2, 2012, Pages 172-178

  Touskova, V ^a   Trachta, P ^a   Kavalkova, P ^a   Drapalova, J ^a   Haluzikova, D ^a   Mraz, M ^a   Lacinova, Z ^a   Marek, J ^a   Haluzik, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adipose tissue; Insulin like growth factor binding protein; Insulin like growth factor 1; Insulin like growth factor 1 receptor; Monocytes; Obesity

Indexed keywords

MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LOW CALORY DIET; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; TISSUE DIFFERENTIATION;

CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION REGULATION; HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; MONOCYTES; OBESITY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT;

EID: 84864348941     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.04.005     Document Type: Article

References (37)

1. Agnese D.M., Calvano J.E., Hahm S.J., Calvano S.E., Lowry S.F. Insulin-like growth factor binding protein-3 is upregulated in LPS-treated THP-1 cells. Surg. Infect. (Larchmt). 2002, 3:119-125.
2. Blüher S., Kratzsch J., Kiess W. Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract. Res. Clin. Endocrinol. Metab. 2005, 19:577-587.
3. Boney C.M., Moats-Staats B.M., Stiles A.D., D'Ercole A.J. Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. Endocrinology 1994, 135:1863-1868.
4. Bourlier V., Bouloumie A. Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes Metab. 2009, 35:251-260.
5. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., Coupaye M., Pelloux V., Hugol D., Bouillot J.L., Bouloumié A., Barbatelli G., Cinti S., Svensson P.A., Barsh G.S., Zucker J.D., Basdevant A., Langin D., Clément K. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54:2277-2286.
6. Che W., Lerner-Marmarosh N., Huang Q., Osawa M., Ohta S., Yoshizumi M., Glassman M., Lee J.D., Yan C., Berk B.C., Abe J. Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ. Res. 2002, 14:1222-1230.
7. Claudio M., Benjamim F., Riccardo B., Massimiliano C., Francesco B., Luciano C. Adipocytes IGFBP-2 expression in prepubertal obese children. Obesity (Silver Spring). 2010, 18:2055-2057.
8. Clemmons D.R., Snyder D.K., Busby W.H. Variable controlling the secretion of insulin-like growth factor binding-2 in normal human subjects. J. Clin. Endocrinol. Metab. 1991, 73:727-878.
9. Del Pozo C.H., Calvo R.M., Vesperinas-García G., Gómez-Ambrosi J., Frühbeck G., Rubio M.A., Obregon M.J. Expression profile in omental and subcutaneous adipose tissue from lean and obese subjects. Repression of lipolytic and lipogenic genes. Obes. Surg. 2011, 21:633-643.
10. Dolezalova R., Lacinova Z., Dolinkova M., Kleiblova P., Haluzikova D., Housa D., Papezova H., Haluzik M. Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Clin. Endocrinol. (Oxf). 2007, 67:674-678.
11. Dolinková M., Dostálová I., Lacinova Z., Michalský D., Haluzíková D., Mráz M., Kasalický M., Haluzík M. The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol. Cell Endocrinol. 2008, 291:63-70.
12. Dunger D., Yuen K., Ong K. Insulin-like growth factor I and impaired glucose tolerance. Horm. Res. 2004, 62:101-107.
13. Frystyk J., Grofte T., Skjaerbaek C., Orskov H. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults. J. Clin. Endocrinol. Metab. 1997, 82:3124-3127.
14. Frystyk J., Skjaerbaek C., Vestbo E., Fisker S., Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab. Res. Rev. 1999, 15:314-322.
15. Grohmann M., Sabin M., Holly J., Shield J., Crowne E., Stewart C. Characterization of differentiated subcutaneous and visceral adipose tissue from children: the influences of TNF-alpha and IGF-I. J. Lipid Res. 2005, 46:93-103.
16. Hoeflich A., Wu M., Mohan S., Föll J., Wanke R., Froehlich T., Arnold G.J., Lahm H., Kolb H.J., Wolf E. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 1999, 140:5488-5496.
17. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 14:860-867.
18. Ikezoe T., Tanosaki S., Krug U., Liu B., Cohen P., Taguchi H., Koeffler H.P. Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells. Blood 2004, 1:237-242.
19. Klöting N., Koch L., Wunderlich T., Kern M., Ruschke K., Krone W., Brüning J.C., Blüher M. Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes 2008, 57:2074-2082.
20. Kluge A., Zimmermann R., Weihrauch D., Mohri M., Sack S., Schaper J., Schaper W. Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heart. Cardiovasc. Res. 1997, 33:324-331.
21. Kooijman R., Willems M., De Haas C.J., Rijkers G.T., Schuurmans A.L., Van Buul-Offers S.C., Heijnen C.J., Zegers B.J. Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 1992, 131:2244-2250.
22. Kooijman R., Willems M., Rijkers G.T., Brinkman A., van Buul-Offers S.C., Heijnen C.J., Zegers B.J. Effects of insulin-like growth factors and growth hormone on the in vitro proliferation of T lymfocytes. J. Neuroimmunol. 1992, 38:95-104.
23. Lacinova Z., Dolinkova M., Haluzikova D., Krajickova J., Haluzik M. Comparison of manual andautomatic (MagNA pure) isolation methods of total RNA from adipose tissue. Mol. Biotechnol. 2008, 38:195-201.
24. Law H.K., Tu W., Liu E., Lau Y.L. Insulin-like growth factor I promotes cord blood T cell maturation through monocytes and inhibits their apoptosis in part through interleukin-6. BMC Immunol. 2008, 17:9-74.
25. Li Z., Picard F. Modulation of IGFBP2 mRNA expression in white adipose tissue upon aging and obesity. Horm. Metab. Res. 2010, 42:787-791.
26. Mraz M., Lacinova Z., Drapalova J., Haluzikova D., Horinek A., Matoulek M., Trachta P., Kavalkova P., Svacina S., Haluzik M. The effect of very-low-calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2011, 96:606-613.
27. Mur C., Arribas M., Benito M., Valverde A.M. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation. Endocrinology 2003, 144:581-593.
28. Peter M.A., Winterhalter K.H., Böni-Schnetzler M., Froesch E.R., Zapf J. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue. Endocrinology 1993, 133:2624-2631.
29. Rajpathak S.N., Gunter M.J., Wylie-Rosett J., Ho G.Y., Kaplan R.C., Muzumdar R., Rohan T.E., Strickler H.D. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab. Res. Rev. 2009, 25:3-12.
30. Rasmussen M.H., Juul A., Kjems L.L., Hilsted J. Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1-4, and IGFBPs-1-3 protease activity in obese subjects. Eur. J. Endocrinol. 2006, 155:575-581.
31. Sato T., Nagafuku M., Shimizu K., Taira T., Igarashi Y., Inokuchi J. Physiological levels of insulin and IGF-1 synergistically enhance the differentiation of mesenteric adipocytes. Cell Biol. Int. 2008, 32:1397-1404.
32. Serri O., Li L., Maingrette F., Jaffry N., Renier G. Enhanced lipoprotein lipase secretion and foam cell formation by macrophages of patients with growth hormone deficiency: possible contribution to increased risk of atherogenesis?. J. Clin. Endocrinol. Metab. 2004, 89:979-985.
33. Stuart C.A., Meehan R.T., Neale L.S., Cintron N.M., Furlanetto R.W. Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J. Clin. Endocrinol. Metab. 1991, 72:1117-1122.
34. Suganami T., Nishida J., Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2062-2068.
35. Wabitsch M., Heinze E., Debatin K.M., Blum W.F. IGF-I- and IGFBP-3-expression in cultured human preadipocytes and adipocytes. Horm. Metab. Res. 2000, 32:555-559.
36. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 2003, 112:1785-1788.
37. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112:1821-1830.